Kyowa Kirin signs US voluntary agreement to lower US medicine costs
Kyowa Kirin announced a voluntary agreement with the U.S. government to improve access and lower the cost of medicines for American patients.
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Kyowa Kirin (KY4.F, 4151.T), a Japan-based Global Specialty Pharmaceutical company, announced a voluntary agreement with the U.S. government to improve access and lower the cost of medicines for American patients.
The company will participate in the GENEROUS mod…